A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys.

about

Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody.

P2860

Q47668280-FFDEC4F2-87D9-48EE-92CA-9F0F88FA2205 Q49915534-DF8E0FDF-F9A5-4E43-8840-D41135682F69

P2860

A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys.

Item

http://www.wikidata.org/entity/Q40311070

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Novel Allosteric Insulin Rec ...... n Diabetic Cynomolgus Monkeys.

@en

type

Item

label

A Novel Allosteric Insulin Rec ...... n Diabetic Cynomolgus Monkeys.

@en

prefLabel

A Novel Allosteric Insulin Rec ...... n Diabetic Cynomolgus Monkeys.

@en

P1476

A Novel Allosteric Insulin Rec ...... n Diabetic Cynomolgus Monkeys.

@en

P2093

Ago Ahene

http://www.w3.org/2001/XMLSchema#string

Bob Shimizu

http://www.w3.org/2001/XMLSchema#string

Jingsong Zhao

http://www.w3.org/2001/XMLSchema#string

Ken Der

http://www.w3.org/2001/XMLSchema#string

Kirk Johnson

http://www.w3.org/2001/XMLSchema#string

Liching Cao

http://www.w3.org/2001/XMLSchema#string

Padma Bezwada

http://www.w3.org/2001/XMLSchema#string

Paul Rubin

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Genetic Syndromes of Severe Insulin Resistance

Naturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology.

Fully human antibodies from transgenic mouse and phage display platforms.

Nonhuman primates and other animal models in diabetes research.

Receptor antibodies as novel therapeutics for diabetes.

Insulin: potential negative consequences of early routine use in patients with type 2 diabetes.

A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.

Quantification of β-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeys.

Selective allosteric antibodies to the insulin receptor for the treatment of hyperglycemic and hypoglycemic disorders.

P304

466-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.115.229690

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26578267

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

hyperglycemia

A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys.

about

P2860

P2860

A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921